French limited company (SA) with capital of € 19 775 052
Registered office : Zone Industrielle de la Vigne aux Loups - 23 rue Bossuet
91160 Longjumeau
745 751 958 R.C.S. Evry
2 0 1 1 s a l e s(in thousands of euros) 2011 2010 % change
First Quarter 44 053 41 434 6,3%including Pharmaceutical Synthesis 27 147 26 603 2,0% including Fine Specialty Chemicals 16 906 14 831 14,0% Second Quarter 41 789 42 698 -2,1% including Pharmaceutical Synthesis 26 457 28 100 -5,8% including Fine Specialty Chemicals 15 332 14 598 5,0% Third Quarter 33 481 33 658 -0,5% including Pharmaceutical Synthesis 19 530 18 394 6,2% including Fine Specialty Chemicals 13 951 15 264 -8,6% Fourth Quarter 45 221 40 721 11,1% including Pharmaceutical Synthesis 28 962 26 282 10,2% including Fine Specialty Chemicals 16 259 14 439 12,6% Total as of 31 December 2011 164 544 158 511 3,8% including Pharmaceutical Synthesis 102 096 99 379 2,7% including Fine Specialty Chemicals 62 448 59 132 5,6%
With sales growing by more than 10% in the fourth quarter of
2011 compared with the same period in 2010, on both
Pharmaceutical Synthesis and Fine Specialty Chemicals,
Dynaction Group's consolidated sales for
2011 are up 3.8% compared to 2010.
Pharmaceutical Synthesis
Over the first five months of the year, business was affected
by the planned reduction in the contribution from the new
contract between PCAS and Sanofi, effective since May, 31th
2010.
Excluding this contract, the Exclusive and Non-Exclusive
Pharma businesses increased by 13.1% over
2011. Fine Specialty Chemicals
The Fine Specialty Chemicals business has continued its
growth, during the fourth quarter being 12.6%
higher than the same period in 2010, giving a full-year
growth of 5.6% for 2011 compared with 2010.
The increase in sales during the fourth quarter should allow
to confirm an increase of the current operating income for
2011.
On December's 14th Board Meeting, PCAS Directors decided to
put end to Mr. Philippe Decazes' contract due to
differences felt concerning the management of operations,
following a few months spent at the head of the PCAS's
executive management team.
Mr. Vincent Touraille, Deputy CEO, will continue to act as
Chief Executive Officer of PCAS.
In order to be able to effectively move forward with the
Group's development strategy, built around increasing
the percentage of proprietary products and developing
differentiating technologies, the Board of Directors of PCAS
has asked the Group's executive management team to focus
their actions on continuing to improve profitability over
2012.
Next date : 2011 earnings, February 22nd, 2012
Dynaction is an industrial holding company focused on a unique development division: Fine Chemicals, its subsidiary PCAS's core business in which it holds a majority stake of 63.65%.
Longjumeau, January 12th 2012
Contact : Philippe
DELWASSE - Chief Executive Officer - Phone : +33 (0)1 69 79
61 32 - www.dynaction.fr
distribué par | Ce noodl a été diffusé par Dynaction SA. Il a été distribué par noodls dans son format d'origine et sans modification sur 2012-01-12 19:12:33 PM et restera accessible depuis ce lien permanent. Cette annonce est protégée par les règles du droit d'auteur et toute autre loi applicable, et son propriétaire est seul responsable de sa véracité et de son originalité. |
Documents associés | |
DYNACTION - 2011 Sales |